Chapter 14 – Biotechnology and Society
14. Individuals with Pompe disease are unable to metabolize _____, and are treated with a human enzyme produced by
_____.
glycogen; transgenic hamster cells
lactose; transgenic crops
cellulose; transgenic hamster cells
fats; cloned hamster cells
14–2: Biopharming: Making Human Proteins in Animals
15. What is one advantage of using transgenic plant cells to produce human proteins for hormone replacement therapy?
Transgenic plants produce lower protein yields than transgenic animals.
Transgenic plants produce higher protein yields than transgenic animals.
Plant cells are less expensive to grow than other cell types.
Transgenic animals cannot produce human proteins.
HIV is spread through proteins harvested from transgenic animals.
14–2: Biopharming: Making Human Proteins in Animals
proteins produced in transgenic animals, transgenic plants, and lab-grown cells.
16. Embryonic stem cells derived from blastocysts are pluripotent, and therefore useful in stem cell research because they
________.
are viable under a wide range of laboratory conditions
do not replicate and are therefore stable long-term
can form all cells, tissues, and organs of the human body
are specialized and therefore arrested in G0
function to replace damaged or diseased body parts in adults
14–3: Using Stem Cells to Treat Disease
cell, and list the functions and developmental potential (pluripotent vs. multipotent) of each.
17. In addition to the promise of disease therapies, the uses of stem cells in medical research include the study of how
_____.
diseases develop and progress before phenotypes are visible
Huntington Disease progresses in its latest stages
to engineer animal models for human disease
to harvest multipotent cells from human blastocysts
to fertilize human eggs in vitro